Your browser doesn't support javascript.
loading
Effectiveness and safety of reduced-dose fluoropyrimidine therapy in patients carrying the DPYD*2A variant: A matched pair analysis.
Henricks, Linda M; van Merendonk, Lisanne N; Meulendijks, Didier; Deenen, Maarten J; Beijnen, Jos H; de Boer, Anthonius; Cats, Annemieke; Schellens, Jan H M.
Afiliação
  • Henricks LM; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Merendonk LN; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Deenen MJ; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Beijnen JH; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • de Boer A; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Cats A; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands.
  • Schellens JHM; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.
Int J Cancer ; 144(9): 2347-2354, 2019 05 01.
Article em En | MEDLINE | ID: mdl-30485432
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Di-Hidrouracila Desidrogenase (NADP) / Deficiência da Di-Hidropirimidina Desidrogenase / Capecitabina / Fluoruracila / Neoplasias / Antimetabólitos Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Di-Hidrouracila Desidrogenase (NADP) / Deficiência da Di-Hidropirimidina Desidrogenase / Capecitabina / Fluoruracila / Neoplasias / Antimetabólitos Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article